Safety of Adalimumab, Ustekinumab, Secukinumab, Guselkumab in Korean Patients with Moderate to…
Request Full Text
- Resource Type
- Journal
- Language
- Korean
- Region
- Korea
- Price
- $68.00
- Article Title
- Safety of Adalimumab, Ustekinumab, Secukinumab, Guselkumab in Korean Patients with Moderate to Severe Psoriasis
- Publication
- Korean Journal of Dermatology
- ISSN
- 0494-4739
- Volume
- 60
- Issue
- 5
- Year
- 2022
- Pages
- 284-290/384-390
- Data Format
- PDF
- Subject Fields
- Dermatology
- Note
- Full text is usually delivered within 1-2 hours
Request Full Text
